High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
1 clinical trials · Condition
◉ Watch High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT05128825) | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | 2022-02-17 |
Track High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.